Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anneal, Astrazeneca, Biocartis, Bluebird, Catalent, Cellectis, Chiesi, Eiger, Emergent, Gossamer, Lantern,Merck KGaA, Novo Nordis, Oregon, Sentynl, Urogen, Zydus.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Helius.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aavantgarde, Arcturis, Amgen, Arrowhead, Aslan, Aubex, Cerevance, Compass Pathways, Merck & Co., Pluri, Sanofi, Stallergenes, Royalty Pharma, Traverse, Zenyaku Kogyo.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Angle, Astrazeneca, Babson, Inomed, Nexstim.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Biomed, Denovo, Luxa, Merck & Co., Mindbio.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Andor Health, Bruker, Deep 6 AI, Detect-Ion, Elitechgroup, Efertility, Intuity Medical, Magnolia Market Access, Nuvo, Valencia Technologies, Vitrolife.

Additional early-stage research and drug discovery news in brief, from: Cero Therapeutics, Defence Therapeutics, Matinas Biopharma, Mythic Therapeutics, Palisade Bio, Promis Neurosciences, Senti Biosciences, Virpax Pharmaceuticals.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Akari, Akili, Amgen, ARS, Biorestorative, Cajal Neuroscience, Cartessa Aesthetics, CSL, Dare, G1, Mission Bio, Peak Bio, Pepper Bio, Pharmadrug, Pharmather, Sairiyo, Sandoz, Shionogi, Xoma.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: GT Medical, Limbus AI, Magventure, Magnus Medical, Pavmed, Radformation, Retispec, Theragenics, Topcon Healthcare, Verantos, Veris.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alnylam, Atossa, Bavarian Nordic, Bayer, BMS, Epygenix, Evotec, Harmony, Medison, Poolbeg, Scenic, Silk Road.